|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,560.00 JPY | -1.01% |
|
+0.98% | +2.43% |
Company Valuation: Kobayashi Pharmaceutical Co., Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 704,427 | 650,295 | 503,841 | 463,131 | 403,511 | 417,560 | - | - |
| Change | - | -7.68% | -22.52% | -8.08% | -12.87% | 3.48% | - | - |
| Enterprise Value (EV) 1 | 596,011 | 546,554 | 424,992 | 398,232 | 333,575 | 359,699 | 347,761 | 341,889 |
| Change | - | -8.3% | -22.24% | -6.3% | -16.24% | 7.83% | -3.32% | -1.69% |
| P/E | 35.8x | 34.8x | 25.3x | 46x | 110x | 41x | 30.8x | 24.9x |
| PBR | 3.59x | 3.47x | 2.47x | 2.18x | 1.92x | 1.98x | 1.93x | 1.87x |
| PEG | - | 12.08x | 7.7x | -0.9x | -1.7x | 0x | 0.9x | 1.1x |
| Capitalization / Revenue | 4.54x | 3.91x | 2.9x | 2.8x | 2.43x | 2.42x | 2.32x | 2.24x |
| EV / Revenue | 3.84x | 3.29x | 2.45x | 2.4x | 2.01x | 2.08x | 1.93x | 1.83x |
| EV / EBITDA | 19.3x | 17.1x | 13.3x | 12.1x | 14.1x | 16.2x | 12.9x | 10.9x |
| EV / EBIT | 22.9x | 20.5x | 16.5x | 16x | 22.4x | 27.4x | 19.9x | 15.9x |
| EV / FCF | 31.8x | 31.1x | -350x | -29.2x | 68.5x | 24.7x | 22.7x | 19.9x |
| FCF Yield | 3.15% | 3.22% | -0.29% | -3.42% | 1.46% | 4.04% | 4.4% | 5.04% |
| Dividend per Share 2 | 83 | 90 | 101 | 102 | 104 | 106 | 109.5 | 114.3 |
| Rate of return | 0.92% | 1% | 1.49% | 1.64% | 1.92% | 1.89% | 1.95% | 2.03% |
| EPS 2 | 252.4 | 259.6 | 268.2 | 135.4 | 49.19 | 137 | 182.5 | 225.4 |
| Distribution rate | 32.9% | 34.7% | 37.7% | 75.3% | 211% | 77.4% | 60% | 50.7% |
| Net sales 1 | 155,252 | 166,258 | 173,455 | 165,600 | 165,742 | 172,560 | 179,820 | 186,639 |
| EBITDA 1 | 30,900 | 32,027 | 31,837 | 32,800 | 23,600 | 22,180 | 27,030 | 31,262 |
| EBIT 1 | 26,065 | 26,669 | 25,780 | 24,860 | 14,923 | 13,125 | 17,494 | 21,464 |
| Net income 1 | 19,715 | 20,022 | 20,338 | 10,067 | 3,656 | 10,255 | 13,674 | 16,493 |
| Net Debt 1 | -108,416 | -103,741 | -78,849 | -64,899 | -69,936 | -57,862 | -69,799 | -75,671 |
| Reference price 2 | 9,040.00 | 9,030.00 | 6,790.00 | 6,230.00 | 5,428.00 | 5,617.00 | 5,617.00 | 5,617.00 |
| Nbr of stocks (in thousands) | 77,923 | 72,015 | 74,203 | 74,339 | 74,339 | 74,339 | - | - |
| Announcement Date | 2/4/22 A | 2/14/23 A | 2/9/24 A | 2/10/25 A | 2/10/26 A | - | - | - |
1JPY in Million2JPY
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 41.01x | 2.08x | 16.22x | 1.89% | 2.62B | ||
| 21.21x | 4.11x | 14.98x | 3.01% | 338B | ||
| 17.88x | 2.72x | 12.02x | 3.52% | 134B | ||
| 25.33x | 3.78x | 15.9x | 2.28% | 73.59B | ||
| 43.29x | 6.98x | 30.27x | 2.13% | 50.87B | ||
| 20.01x | 2.8x | 11.74x | 4.45% | 36.59B | ||
| 84.32x | 2.49x | 14.98x | 1.61% | 31.76B | ||
| 24.42x | 1.79x | 11.39x | 2.09% | 21.23B | ||
| 16.21x | 1.56x | 8.86x | 3.26% | 19.81B | ||
| 21.02x | 1.36x | 8.68x | 1.24% | 20.08B | ||
| Average | 31.47x | 2.97x | 14.50x | 2.55% | 72.81B | |
| Weighted average by Cap. | 25.27x | 3.67x | 14.99x | 2.91% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 4967 Stock
- Valuation Kobayashi Pharmaceutical Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
















